We are live on
!
Find out more
HCM
Highline Capital Management Portfolio holdings
AUM
$53.5M
1-Year Est. Return
21.72%
This Fund
S&P 500
This Quarter
Est. Return
+6.44%
1 Year Est. Return
-21.72%
3 Year Est. Return
+197.64%
5 Year Est. Return
+251.63%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
-$225M
(-14%)
Cap. Flow
-$275M
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
53.86%
Holding
48
New
13
Increased
4
Reduced
14
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$94.2M |
| 2 |
ArcelorMittal
MT
|
+$58.7M |
| 3 |
SAFM
Sanderson Farms Inc
SAFM
|
+$54.5M |
| 4 |
Tyson Foods
TSN
|
+$49.8M |
| 5 |
Sysco
SYY
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
+$92.6M |
| 2 |
Royal Caribbean
RCL
|
+$60.7M |
| 3 |
Rio Tinto
RIO
|
+$57.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$52M |
| 5 |
Moelis & Co
MC
|
+$45.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.59% |
| 2 | Consumer Discretionary | 21.98% |
| 3 | Consumer Staples | 10.86% |
| 4 | Technology | 7.89% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
1
DELISTED
CATALENT, INC.
CTLT
| $111M | 8.16% |
+2,056,709
| New | +$94.2M |
|
2
IQVIA
IQV
$34.7B
| $90.2M | 6.6% |
560,826
-192,770
| -26% | -$27M |
|
3
Commercial Metals
CMC
$7.63B
| $79.1M | 5.79% |
4,434,008
+395,000
| +10% | +$6.46M |
|
|
GRA
4
DELISTED
W.R. Grace & Co.
GRA
| $74.1M | 5.43% |
974,080
+37,680
| +4% | +$2.82M |
|
5
Caesars Entertainment
CZR
$6.1B
| $71.1M | 5.2% |
1,542,845
-80,900
| -5% | -$3.97M |
|
6
Elevance Health
ELV
$81.9B
| $69.4M | 5.08% |
246,000
-32,858
| -12% | -$8.98M |
|
|
7
Royal Caribbean
RCL
$78.7B
| $67.5M | 4.94% |
557,250
-498,000
| -47% | -$60.7M |
|
8
Take-Two Interactive
TTWO
$43B
| $64.4M | 4.71% |
567,100
-79,000
| -12% | -$8.13M |
|
|
9
ArcelorMittal
MT
$50.4B
| $56.1M | 4.11% |
+3,112,400
| New | +$58.7M |
|
|
SAFM
10
DELISTED
Sanderson Farms Inc
SAFM
| $52.4M | 3.84% |
+383,945
| New | +$54.5M |
|
|
11
Tyson Foods
TSN
$20.2B
| $52.2M | 3.82% |
+646,100
| New | +$49.8M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.5B
| $52M | 3.8% |
607,021
-459,228
| -43% | -$39.3M |
|
13
Marvell Technology
MRVL
$174B
| $49.7M | 3.64% |
2,083,400
-538,000
| -21% | -$12.6M |
|
14
PUT
Apple
AAPL
$4.89T
| $48.7M | 3.57% |
+985,200
| New | +$48M |
|
15
Boyd Gaming
BYD
$6.47B
| $48M | 3.51% |
1,781,139
-400,800
| -18% | -$11M |
|
16
VICI Properties
VICI
$29.4B
| $46.3M | 3.39% |
2,098,660
-25,000
| -1% | -$558K |
|
|
17
Sysco
SYY
$39.7B
| $43.7M | 3.2% |
+618,500
| New | +$44M |
|
|
MTOR
18
DELISTED
MERITOR, Inc.
MTOR
| $39.6M | 2.9% |
1,633,980
-271,800
| -14% | -$6.11M |
|
19
UroGen Pharma
URGN
$2B
| $36.4M | 2.67% |
1,014,078
+27,200
| +3% | +$1M |
|
20
Pegasystems
PEGA
$4.41B
| $35.8M | 2.62% |
1,006,576
-300,000
| -23% | -$10.7M |
|
21
Align Technology
ALGN
$12B
| $27.5M | 2.01% |
+100,500
| New | +$30.3M |
|
|
SAFM
22
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $27.3M | 2% |
+200,000
| New | +$28.4M |
|
23
Ultragenyx Pharmaceutical
RARE
$2.65B
| $24.8M | 1.81% |
390,453
-219,610
| -36% | -$14M |
|
|
GLUU
24
DELISTED
Glu Mobile Inc.
GLUU
| $22.3M | 1.63% |
+3,102,500
| New | +$28.5M |
|
|
FPAC.U
25
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $22.2M | 1.62% |
2,076,099
| – | – |
|
Similar funds
NHSP
DTIM
BI
MCAI
PCM
FC
AEPIP
SAM
Highline Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Highline Capital Management held 48 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Highline Capital Management withdrew a net $275M in Q2 2019, closing 16 positions and reducing 14 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $92.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 30% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Highline Capital Management opened a new position in CATALENT, INC. worth $111M.
- Highline Capital Management's largest Q2 2019 buy was CATALENT, INC.: 2,056,709 shares worth $111M.
- Highline Capital Management added most to Commercial Metals in Q2 2019, an estimated $6.46M increase.
- Highline Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $60.7M.
- Highline Capital Management fully exited Berry Global Group, Inc. in Q2 2019, selling an estimated $92.6M.
- Highline Capital Management's ten largest holdings make up 54% of its $1.37B portfolio in Q2 2019.
- Highline Capital Management opened 13 new positions and closed 16 in Q2 2019.
- Highline Capital Management's portfolio value fell 14% quarter-over-quarter to $1.37B.
Based on Highline Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.